Medivir, Novadex Pharmaceuticals deal

Medivir acquired from Novadex a portfolio of preclinical antiviral programs, including nucleotide polymerase inhibitors. Medivir said the portfolio includes IP and prodrug technologies that can "further strengthen" its HCV platform. Novadex received an undisclosed upfront payment and is eligible for milestones. ...